Search Results

Filter
  • 1-10 of  450 results for ""MYC oncogenes""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

MYC oncogenes and human neoplastic disease.

  • Authors : Nesbit CE; Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania 15213, USA.; Tersak JM

Subjects: Genes, myc/Genes, myc/Genes, myc/*physiology ; Neoplasms/Neoplasms/Neoplasms/*genetics; Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/genetics

  • Source: Oncogene [Oncogene] 1999 May 13; Vol. 18 (19), pp. 3004-16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.

  • Authors : Okimoto T; Department of Biochemistry, Kyushu University, School of Medicine, Fukuoka, Japan.; Kohno K

Subjects: Gene Expression Regulation, Neoplastic*; ErbB Receptors/ErbB Receptors/ErbB Receptors/*genetics ; Genes, myc/Genes, myc/Genes, myc/*genetics

  • Source: Oncogene [Oncogene] 1996 Apr 18; Vol. 12 (8), pp. 1625-33.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.

Subjects: Genes, abl* ; Genes, myc*; Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/*genetics

  • Source: Oncogene [Oncogene] 1992 Apr; Vol. 7 (4), pp. 811-9.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.

  • Authors : Sullivan DK; Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; UCLA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.

Subjects: Genes, myc* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; Mice

  • Source: Oncogene [Oncogene] 2022 Nov; Vol. 41 (45), pp. 4960-4970. Date of Electronic Publication: 2022 Oct 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro.

  • Authors : Choi HI; Department of Bionanotechnology, Hanyang University, Seoul, 04673, Republic of Korea.; An GY

Subjects: RNA, Untranslated*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology

  • Source: Scientific reports [Sci Rep] 2022 Jan 17; Vol. 12 (1), pp. 855. Date of Electronic Publication: 2022 Jan 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.

  • Authors : Pan Z; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Pathology, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Epidermal Growth Factor/Epidermal Growth Factor/Epidermal Growth Factor/*metabolism ; Genes, myc/Genes, myc/Genes, myc/*genetics

  • Source: Oncogene [Oncogene] 2021 Apr; Vol. 40 (14), pp. 2581-2595. Date of Electronic Publication: 2021 Mar 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

G-quadruplex binding properties of a potent PARP-1 inhibitor derived from 7-azaindole-1-carboxamide.

  • Authors : Dallavalle S; Department of Food, Environmental and Nutritional Sciences (DEFENS), University of Milan (Università Degli Studi Di Milano), Milan, Italy.; Musso L

Subjects: G-Quadruplexes* ; Genes, myc*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*metabolism

  • Source: Scientific reports [Sci Rep] 2021 Feb 16; Vol. 11 (1), pp. 3869. Date of Electronic Publication: 2021 Feb 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Evolutionary-driven C-MYC gene expression in mammalian fibroblasts.

  • Authors : Moura MT; Department of Veterinary Medicine, Federal Rural University of Pernambuco-UFRPE, Recife, Brazil. .; Silva RLO

Subjects: Evolution, Molecular* ; Genes, myc*; Cattle/Cattle/Cattle/*genetics

  • Source: Scientific reports [Sci Rep] 2020 Jul 06; Vol. 10 (1), pp. 11056. Date of Electronic Publication: 2020 Jul 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma.

  • Authors : Wang J; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China.; Medical Research Institute, Wuhan University, 430071, Wuhan, China.

Subjects: Genes, myc*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Neuroblastoma/Neuroblastoma/Neuroblastoma/*drug therapy

  • Source: Oncogene [Oncogene] 2019 Oct; Vol. 38 (41), pp. 6737-6751. Date of Electronic Publication: 2019 Aug 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Generation of c-MycER TAM -transduced human late-adherent olfactory mucosa cells for potential regenerative applications.

Subjects: Genes, myc*; Olfactory Mucosa/Olfactory Mucosa/Olfactory Mucosa/*cytology ; Recombinant Proteins/Recombinant Proteins/Recombinant Proteins/*genetics

  • Source: Scientific reports [Sci Rep] 2019 Sep 13; Vol. 9 (1), pp. 13190. Date of Electronic Publication: 2019 Sep 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
  • 1-10 of  450 results for ""MYC oncogenes""